FEZF1 and non-small cell lung carcinoma: As described in previously studies (Bian et al., 2018), lncRNA FEZF1-AS1 was upregulated in primary colorectal carcinoma (CRC), non-small cell lung cancer (NSCLC) as well as GC tissues and cells, and the overexpression of ncRNA FEZF1-AS1 was correlated with poor prognosis.